No Data
No Data
Is Yili Chuanning BiotechnologyLtd (SZSE:301301) Using Too Much Debt?
Yili Chuanning Biotechnology Gets Nod to Market Ursodeoxycholic Acid
Chuanning Biology (301301.SZ): Synthetic biology products such as red Sandalwood alcohol, Squalene, 5-Hydroxytryptophan, Inositol have entered the production stage.
On July 8th, Gelon Hui reported that Chuanning Biology (301301.SZ) has announced on the investor platform that its synthetic biology products, including resveratrol, squalene, 5-hydroxytryptophan, and inositol, have now entered the production phase.
Yili Chuanning Biotechnology: 2024 Interim Performance Forecast
Express News | Yili Chuanning Biotechnology Sees H1 Net Profit Ranging 730 Mln-770 Mln Yuan, up 86.8%-97% Y/Y
Chuanning Biotech (301301.SZ) is expected to increase net income by 86.76%-97.00% in the first half of the year.
On July 7th, Gelonhui announced that Chuanning Biology (301301.SZ) is expected to have a net income of 730-770 million yuan attributable to shareholders of listed companies from January 1, 2024 to June 30, 2024, an increase of 86.76%-97.00% compared to the same period last year. After deducting non-recurring gains and losses, the net profit is expected to be 730-770 million yuan, an increase of 85.95%-96.14% year-on-year. The main reasons for the growth of performance in this reporting period are: 1. due to increased market demand, the company's main products have risen in both volume and price, and revenue has increased year-on-year.
No Data